Peptide Library

FDA-approved

Digestive & weight

Setmelanotide

Evidence

FDA approved

Class

Melanocortin 4 receptor agonist

/

Setmelanotide

KEY TAKEAWAY

Setmelanotide is a synthetic cyclic peptide that activates the melanocortin 4 receptor in the brain. It is sold as Imcivree. The FDA approved setmelanotide (Imcivree) in 2020 for obesity due to certain rare genetic disorders, and has expanded its use since.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

Melanocortin 4 receptor agonist

Approved for

Obesity caused by specific rare genetic conditions, including Bardet-Biedl syndrome

Key fact

The FDA approved setmelanotide (Imcivree) in 2020 for obesity due to certain rare genetic disorders, and has expanded its use since.

Route

Daily subcutaneous injection

Evidence strength

FDA approved

What it is

What it is

Setmelanotide is a synthetic cyclic peptide that activates the melanocortin 4 receptor in the brain. It is sold as Imcivree.

How it works

How it works

It restores activity in the brain pathway that controls hunger and energy use when that pathway is impaired by certain rare genetic conditions.

Regulatory status

Regulatory status

The FDA approved setmelanotide (Imcivree) in 2020 for obesity due to certain rare genetic disorders, and has expanded its use since.

What it is used for

What it is used for

Obesity caused by specific rare genetic conditions, including Bardet-Biedl syndrome.

Side effects and risks

Side effects and risks

Skin darkening, injection-site reactions and nausea are reported. Depression and suicidal thoughts need monitoring.

Citations

Citations

U.S. FDA prescribing information for Setmelanotide. DailyMed, National Library of Medicine.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo